Relay Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Media:
Dan Budwick
1AB
(973) 271-6085
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Synaffix Announces License Agreement with Mersana Therapeutics for the Use of its GlycoConnect™ Site-Specific ADC Technology Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Read more...
 
Synaffix Announces License Agreement with Mersana Therapeutics for the Use of its GlycoConnect™ Site-Specific ADC Technology Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Read more...
 
Generation Bio to Present at 37th Annual J.P. Morgan Healthcare Conference Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Investor:
Stern Investor Relations
(212) 362-1200
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Media:
Marissa Picerno, Ten Bridge Communications
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
518-817-2176
Read more...
 
Generation Bio to Present at 37th Annual J.P. Morgan Healthcare Conference Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Investor:
Stern Investor Relations
(212) 362-1200
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Media:
Marissa Picerno, Ten Bridge Communications
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
518-817-2176
Read more...
 
Recursion Signs Global Licensing Agreement with the Ohio State Innovation Foundation to Develop REC-2282 to Treat Neurofibromatosis Type 2 Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Jessica Yingling, Ph.D.
Little Dog Communications
+1-858-344-8091
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Recursion Signs Global Licensing Agreement with the Ohio State Innovation Foundation to Develop REC-2282 to Treat Neurofibromatosis Type 2 Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Jessica Yingling, Ph.D.
Little Dog Communications
+1-858-344-8091
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Catabasis Pharmaceuticals Appoints Gregg Lapointe to its Board of Directors Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Investor and Media Contact
Andrea Matthews
Catabasis Pharmaceuticals, Inc.
T: (617) 349-1971
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Catabasis Pharmaceuticals Appoints Gregg Lapointe to its Board of Directors Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Investor and Media Contact
Andrea Matthews
Catabasis Pharmaceuticals, Inc.
T: (617) 349-1971
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Pear Therapeutics Completes $64M Series C Financing Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Cross-Disciplinary Syndicate Provides Growth Capital to Advance Prescription Digital Therapeutics
Read more...
 
Pear Therapeutics Completes $64M Series C Financing Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Cross-Disciplinary Syndicate Provides Growth Capital to Advance Prescription Digital Therapeutics
Read more...
 
Global Von Willebrand Disease Treatment Market 2019-2023| Increase in Patient Assistance Programs Impacting Market Growth| Technavio Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
Read more...
 
Global Von Willebrand Disease Treatment Market 2019-2023| Increase in Patient Assistance Programs Impacting Market Growth| Technavio Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com
Read more...
 
Grey Wolf Animal Health Announces the Acquisition of Veterinary Healthcare Solutions Inc. Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Strategic acquisition provides national presence to accelerate growth across Canada
Read more...
 
Grey Wolf Animal Health Announces the Acquisition of Veterinary Healthcare Solutions Inc. Print E-mail
Business Wire
Friday, 04 January 2019 02:06
Strategic acquisition provides national presence to accelerate growth across Canada
Read more...
 
<< Start < Prev 331 332 333 334 335 336 337 338 339 340 Next > End >>

Page 333 of 375

Newsletter